Villette CC, Dupuy N, Brightman FA, Zimmermann A, et al. Semi-mechanistic efficacy model for PARP + ATR inhibitors-application to rucaparib and talazoparib in combination with gartisertib in breast cancer PDXs. Br J Cancer 2025 Jan 28. doi: 10.1038/s41416-024-02935.
PMID: 39875558